Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | AMGN | BMY | VRTX | GILD |
| Company | Ascendis Pharma ADR | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 123.45 | 288.18 | 58.16 | 454.24 | 89.07 |
| High | 124.63 | 291.11 | 58.48 | 455.43 | 89.94 |
| Low | 122.43 | 284.14 | 57.47 | 445.00 | 88.07 |
| Last | 122.98 | 289.88 | 58.26 | 449.90 | 89.87 |
| Change | -1.40 | +2.01 | +0.38 | -1.33 | +1.24 |
| % Change | -1.13% | +0.70% | +0.66% | -0.29% | +1.40% |
| Volume | 139,061 | 1,954,906 | 5,062,795 | 993,909 | 2,331,233 |
| 20-Day Average Volume | 464,697 | 2,836,219 | 12,262,209 | 1,316,880 | 7,435,573 |
| Previous Close | 124.38 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 125.92 | 307.46 | 55.92 | 479.20 | 90.89 |
| 20-Day Raw Stochastic | 31.75% | 28.83% | 69.69% | 6.14% | 28.43% |
| 20-Day Relative Strength | 43.43% | 37.17% | 60.80% | 40.71% | 53.51% |
| Weighted Alpha | +6.86 | +2.33 | +26.17 | +17.82 | +26.00 |
| Today's Opinion | 72% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 56% Sell | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.95% since 11/14/24 | -1.75% since 11/14/24 | -0.39% since 11/14/24 | -7.07% since 11/14/24 | -2.59% since 11/14/24 |
| Low | 118.05 on 11/15/24 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.13 on 11/21/24 | 86.08 on 11/19/24 |
| High | 133.00 on 11/15/24 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | -4.32% since 10/21/24 | -8.21% since 10/21/24 | +11.80% since 10/21/24 | -5.93% since 10/21/24 | +3.98% since 10/21/24 |
| Low | 118.05 on 11/15/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.13 on 11/21/24 | 85.60 on 10/22/24 |
| High | 133.97 on 10/28/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -10.14% since 08/21/24 | -11.67% since 08/21/24 | +20.29% since 08/21/24 | -7.49% since 08/21/24 | +19.43% since 08/21/24 |
| Low | 111.09 on 09/12/24 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.13 on 11/21/24 | 75.35 on 08/22/24 |
| High | 155.53 on 09/20/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +0.21% since 05/21/24 | -7.65% since 05/21/24 | +37.85% since 05/21/24 | +1.75% since 05/21/24 | +33.34% since 05/21/24 |
| Low | 111.09 on 09/12/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 155.53 on 09/20/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,542,651 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 60,642 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 288,670,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -521,070,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 63,590,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -109,080,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.66 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.89 on 11/14/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/14/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |